Article
Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854 902 patients
4 Sept 2002
Abstract excerpt
OBJECTIVES: In France, maternal serum marker screening is governed by specific legislation. We conducted a study of the countrywide trisomy 21 screening based on second trimester maternal serum markers. METHODS: We reviewed the medical records of 854,902 patients prospectively screened for second trimester maternal serum markers in the 60 authorized laboratories over the two-year period 1997-1998. All patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
